Streetbeat News

Equity Actions

EQIX

Equinix (NASDAQ:EQIX) has been reviewed by 4 analysts over the past three months, with mixed sentiments. The average 12-month price target is $836.25, a 5.59% increase from the previous target. Analysts from Barclays, Truist Securities, Morgan Stanley, and Oppenheimer have adjusted their ratings and price targets. Equinix operates 248 data centers globally and serves over 10,000 customers. Financially, it has shown revenue growth but has below-average net margin and ROE, with a strong ROA and a healthy debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 9:00 pm

ONB

Old National Bancorp (NASDAQ:ONB) has been analyzed by four analysts in the last quarter, with mixed opinions ranging from bullish to bearish. The average 12-month price target is $18.25, with a high of $21.00 and a low of $16.00, marking a 7.22% decrease in the average target. Analysts from Stephens & Co., UBS, Citigroup, and Piper Sandler have adjusted their ratings and price targets. Old National, a financial services bank holding company, has shown a slight decline in revenue growth, an impressive net margin of 31.54%, a strong ROE of 2.86%, and an ROA of 0.29%, but carries a higher debt-to-equity ratio of 1.09.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 9:00 pm

COP

Analysts have provided mixed reviews on ConocoPhillips (NYSE:COP) over the past three months, with ratings ranging from bullish to indifferent. The average 12-month price target is $137.17, with a high of $141.00 and a low of $132.00, marking a 3.96% decrease from the previous average. Recent actions include both lowered and raised price targets by analysts from firms such as Raymond James, Mizuho, UBS, JP Morgan, and RBC Capital. ConocoPhillips is a major exploration and production firm with significant operations and reserves. Despite a recent revenue decline of -32.18%, the company maintains a strong net margin and ROA, but its ROE is below industry average. Its debt-to-equity ratio is considered healthy.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 8:01 pm

ACN

Six analysts have recently updated their ratings on Accenture (NYSE:ACN), with varying perspectives from bullish to bearish. The average 12-month price target is now $375.5, an 8.68% increase from the previous $345.50. Analysts from firms like Morgan Stanley, BMO Capital, UBS, Wedbush, and Redburn Atlantic have raised their price targets, indicating a positive outlook on Accenture's performance. The company has shown strong financial health with a market capitalization above industry average, a revenue growth rate of 3.03%, a net margin of 12.16%, an ROE of 7.54%, an ROA of 3.84%, and a low debt-to-equity ratio of 0.12.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 8:00 pm

CG

Analysts have recently updated their ratings and price targets for Carlyle Group (NASDAQ:CG), with 6 analysts offering views ranging from bullish to bearish. The average 12-month price target is now $38.67, up 5.22% from the previous $36.75. Analysts from Morgan Stanley, Citigroup, JP Morgan, TD Cowen, and Evercore ISI Group have provided updated ratings and price targets. Carlyle Group is a major alternative-asset manager with $382.3 billion in AUM. However, the company has seen a revenue decline of -22.91% and faces challenges with market capitalization, net margin, ROE, ROA, and a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 8:00 pm

AR

Antero Resources (NYSE:AR) received mixed analyst ratings with 3 bullish, 1 somewhat bullish, and 2 indifferent. The average 12-month price target is $27.83, down 16.17% from the previous $33.20. Analysts from Raymond James, Benchmark, Mizuho, Wells Fargo, and Truist Securities have adjusted their ratings and price targets. Antero Resources is engaged in natural gas and liquids production, with a market cap below industry average, a -56.22% revenue decline as of September 30, 2023, low net margin, ROE, and ROA, and a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 8:00 pm

EVAX

MRK

Evaxion Biotech A/S (NASDAQ:EVAX) stock is trading higher due to the company's announcement of an expanded commitment to developing cancer vaccines targeting Endogenous Retroviruses (ERVs) using AI-Immunology. ERVs, which are overexpressed in cancer cells, present a new treatment opportunity that could extend to patients unresponsive to conventional immunotherapy. Evaxion is initiating preclinical activities aiming for Proof-of-Concept data by H2 2024. The stock's volume surged to 1.95 million compared to its 100-day average of 33.377K. In December, Evaxion closed a $5.3 million private placement with Merck & Co Inc's (NYSE:MRK) venture capital arm being a significant investor. Merck reported an 11.4% stake in Evaxion as of December 21, 2023. EVAX shares have risen 97% to $9.29.

Portfolio Pulse from Vandana Singh

January 24, 2024 | 7:08 pm

BUD

Anheuser-Busch InBev's (NYSE:BUD) short interest has increased by 25% since the last report, with 4.25 million shares sold short, representing 0.25% of available shares. It would take about 3.42 days to cover these short positions based on average trading volume. While an increase in short interest can indicate bearish sentiment, BUD's short interest is still below its peer group average of 4.64%. This data does not necessarily predict a price drop but suggests traders are shorting more shares.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 6:45 pm

AVXL

Anavex Life Sciences (NYSE:AVXL) has seen a 10.79% increase in short interest since the last report, with 20.07 million shares sold short, representing 25.26% of its float. It would take about 11.37 days to cover all short positions. While this rise in short interest could indicate bearish sentiment, it doesn't necessarily predict a price drop. Compared to its peers, Anavex has a higher short interest percentage, with the peer group average at 14.82%.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 6:45 pm

PTON

Peloton Interactive (NYSE:PTON) has seen an 8.76% increase in short interest since its last report, with 47.89 million shares sold short, representing 15.76% of its float. The current short interest suggests a bearish sentiment among investors, as it exceeds the peer group average of 8.13%. However, high short interest can sometimes be bullish, indicating a potential for a short squeeze.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 6:45 pm